Inventor · disambiguated record
Minglong Hu
Also filed as: HU MINGLONG
6 granted patents·5 pending applications·7 citations·filing 2018–2024
73Inventor score
Top patents by PatentIndex Score
11 records- 0178US11993664B2Crystalline form of compound and uses thereof in medicineWATERSTONE PHARMACEUTICALS WUHAN CO LTD·Filed 2019·Granted May 28, 2024·2 cites·9 claims
- 0278US11845809B2Maleate of SCY-635 and uses thereof in medicineWATERSTONE PHARMACEUTICALS WUHAN CO LTD·Filed 2018·Granted Dec 19, 2023·2 cites·5 claims
- 0370US12478638B2Polymers, compositions and methods for treating hyperuricemiaWATERSTONE PHARMACEUTICALS WUHAN CO LTD·Filed 2022·Granted Nov 25, 2025·0 cites·13 claims
- 0468US2023102317A1Polymer medicament for treating hyperkalemia and preparation method thereofWATERSTONE PHARMACEUTICALS WUHAN CO LTD·Filed 2022·Application pending·0 cites
- 0559US2024307485A1Ws635 uses thereof in medicineWATERSTONE PHARMACEUTICALS WUHAN CO LTD·Filed 2024·Application pending·0 cites
- 0658US2024016884A1Ws635 uses thereof in medicineWATERSTONE PHARMACEUTICALS WUHAN CO LTD·Filed 2023·Application pending·0 cites
- 0755USD1067689SGaming tableBENGBU LONGHE ELECTRONIC COMMERCE CO LTD·Filed 2023·Granted Mar 25, 2025·2 cites·1 claims
- 0851US2024139234A1Pharmaceutical polymer for treating hyperkalemia and preparation method thereofWATERSTONE PHARMACEUTICALS WUHAN CO LTD·Filed 2021·Application pending·0 cites
- 0948USD1084710SGaming deskBENGBU LONGHE ELECTRONIC COMMERCE CO LTD·Filed 2023·Granted Jul 22, 2025·1 cites·1 claims
- 1047US2022296676A1Treatment or prevention of coronaviridae infectionWATERSTONE PHARMACEUTICALS WUHAN CO LTD·Filed 2020·Application pending·0 cites
- 1146US12226446B2WS-635 uses thereof in medicineWATERSTONE PHARMACEUTICALS WUHAN CO LTD·Filed 2019·Granted Feb 18, 2025·0 cites·17 claims
Join the waitlist — get patent alerts
Get an alert when Minglong Hu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →